Pfizer’s planned US$7.3 billion acquisition of weight-loss therapy maker Metsera has entered a new phase, after rival Novo Nordisk launched a surprise counterbid. Pfizer has launched a legal attempt to block the rival bid.
Pfizer escalates planned takeover of Metsera after Novo Nordisk enters the fray
November 1, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
If this is an example of a bully playing hardball, it's not the companies
July 21, 2026 - - Latest News -
LTR Pharma secures national US manufacturing and fulfilment partner
July 21, 2026 - - Latest News -
Candidate shows antidepressant signal in difficult to treat depression
July 21, 2026 - - Latest News -
'Our access. Our medicines. Our vaccines. Our medical technology'
July 21, 2026 - - Latest News -
Novartis names Anne Harris to lead Australia and New Zealand
July 20, 2026 - - Latest News -
Why is the system slower than when there was no patient involvement or input?
July 20, 2026 - - Latest News -
No company in its right mind would risk a large private market for this outcome?
July 20, 2026 - - Latest News

